Seeking catalyst driven opportunity
Shares of IonQ Inc. IONQ enjoyed a quantum leap of 33.48% in a single day to close Wednesday at $39.39. The catalyst? A perfect storm of bullish momentum driving investor buying, including a Microsoft-powered tailwind and a $1 billion deal securing Maryland as the new …
LOS ANGELES, Jan. 15, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO …
When it comes to widely followed Wall Street money managers, Berkshire Hathaway‘s (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett is in a class of his own. In the roughly six decades since taking the reins, the aptly named “Oracle of Omaha” has overseen an aggregate return …
Investors in Netflix Inc (Symbol: NFLX) saw new options begin trading today, for the May 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 121 days until expiration …
The iShares Morningstar Mid-Cap ETF is seeing unusually high volume in afternoon trading Monday, with over 254,000 shares traded versus three month average volume of about 39,000. Shares of IMCB were trading flat on the day. Components of that ETF with the highest volume on …
If you’ve made it this far, you’ve passed the test. Chinese stocks aren’t very popular with stateside investors these days. With tariffs about to muddy up a trade war and TikTok’s ban hanging in the balance, it’s easy to sidestep exposure to China when there’s …
NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) — AlayaCare, a leading provider of cloud-based home care solutions, is proud to announce the launch of Layla, an AI-powered conversational agent designed to revolutionize home-based care delivery. Integrated seamlessly within the AlayaCare platform, Layla provides caregivers and …
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Rigel Pharmaceuticals RIGL: This clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases, has seen the Zacks Consensus Estimate …
Artificial intelligence quite evidently seems to have been a growth driver for computer memory and data storage specialist Micron Technology Inc MU. Throughout the first half of last year, MU stock shot skyward, at one point exceeding $150 per share. However, starting from the back …
LOS ANGELES, Jan. 14, 2025 /PRNewswire/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX. IF YOU SUFFERED A LOSS ON YOUR KYVERNA INVESTMENTS, …